Showing results (131-140 of 283) with videos related to

Sort By:
Pageof 29
British Journal of Cancer|May 1, 1994
Formation and loss of O6-methyldeoxyguanosine in human leucocyte DNA following sequential DTIC and fotemustine chemotherapyS M Lee, G P Margison, N Thatcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapyJ Prendiville, J Radford, N Thatcher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomitingH Anderson, N Thatcher, A Howell, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 1, 1993
The suitability of carboplatin solutions for 14-day continuous infusion by ambulatory pump: an HPLC-dynamic FAB studyJ A Hadfield, A T McGown, M J Dawson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesotheliomaS C White, H Anderson, G C Jayson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancerP J Woll, J Hodgetts, L Lomax, et al.
International Journal of Cancer|January 2, 1992
Haemopoietic cell kinetics in humans treated with rGM-CSFB I Lord, H Gurney, J Chang, et al.
British Journal of Cancer|June 1, 1990
Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibodyH Dazzi, P S Hasleton, N Thatcher, et al.
British Journal of Cancer|December 1, 1988
The value of tumour markers in lung cancerS A Gomm, B G Keevil, N Thatcher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysisJ Prendiville, N Thatcher, M Lind, et al.
Pageof 29